Cargando…
The Therapeutic Value of Monoclonal Antibodies Directed Against Immunogenic Tumor Glycoproteins
Monoclonal antibodies developed against immunogenic proteins (Tumor Specific Antigens/TSA's) that are expressed in human cancers, display a unique behavioral pattern. They appear to serve in a dual role. This includes the early recognition of these immunogenic membrane proteins that can serve a...
Autores principales: | Arlen, Myron, Arlen, Philip, Tsang, Al, Wang, XuePing, Gupta, Rishab |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974238/ https://www.ncbi.nlm.nih.gov/pubmed/21060731 |
Ejemplares similares
-
Nanocytology vs. Immunohistochemistry of Intestinal Colonocytes to Assess the Risk of Colon Cancer based on Field Cancerization - A Preliminary Report
por: Arlen, Myron, et al.
Publicado: (2013) -
Optimizing the Immune System to Achieve Control of the Metastatic Malignant Lesion
por: Arlen, Myron, et al.
Publicado: (2013) -
Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas
por: Tsang, Kwong yok, et al.
Publicado: (2022) -
An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells
por: Fantini, Massimo, et al.
Publicado: (2019) -
Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201
por: Tsang, Kwong Y., et al.
Publicado: (2022)